摘要
目的 研究CA12 5和CEA联合检测在非小细胞肺癌 (NSCLC)诊治中的临床意义。方法 NSCLC患者 112例 ,男 6 4例 ,女 4 8例。其中腺癌 5 6例 ,鳞癌 32例 ,大细胞或其他类型 2 4例。以CA12 5 >35U/ml,CEA >15ng/ml为阳性结果。结果 CA12 5和CEA水平随着病情程度分级的增加而增加 ,化疗后CA12 5和CEA有一定程度的下降。结论 CA12 5和CEA是疾病程度的预测指标 ,CEA、CA12 5联合检测在肺癌诊治中有互相补充作用。
Objective To study the clini cal s ignificance of tumor markers CA125 and CEA in non-small cell lung cancer. Methods Fifty-six patients with adenocarc inoma, 32 patients with squamous cell carcinoma,and 24 patients with large cell carcinoma or not-otherwise-specified(other) were studied.The critical val ues of serum CA125 le vel and CEA were respectively 35 U/ml and 15 ng/ml.Results The levels of CA125 and CEA increased with increasing stage of disease, and decreased to a certain degre e after chemotherapy.Conclusion CA 125 and CEA are useful indicators of severity of disease,and may potentially hav e important prognostic value.
出处
《中国肿瘤临床与康复》
2004年第3期210-212,共3页
Chinese Journal of Clinical Oncology and Rehabilitation
关键词
肺肿瘤
癌胚抗原
糖链抗原125
Lung neoplasm
Carbohydrate a ntigen 125
Carcinoembryonic antigen
